Navigation Links
Actelion Announces Multiple Presentations on Tracleer(R) and the REVEAL Registry at CHEST 2007
Date:10/19/2007

CHICAGO, Oct. 19 /PRNewswire/ -- Actelion Ltd (SWX: ATLN) today announced multiple presentations regarding Tracleer(R) (bosentan), including new Phase 3 data assessing the efficacy and safety of Tracleer in combination with sildenafil, and data obtained from the first 1,500 patients with pulmonary arterial hypertension (PAH) enrolled in the REVEAL(TM) (Registry to EValuate Early And Long-term PAH Disease Management) Registry. The presentations and publications are part of the proceedings at CHEST 2007, the annual meeting of the American College of Chest Physicians, being held October 20-25, 2007 at McCormick Place in Chicago, IL. The company will be exhibiting at booth # 239 in the Exhibit Hall.

The presentations and abstracts -- including date and location for each -- are as follows:

Tuesday, October 23, 2007, 12:30 p.m. - 2:00 p.m.

Session: Pulmonary Vascular Disease: Evaluation and Treatment, ID #858

Oral Presentation: REVEAL Registry: Baseline Characteristics of the First

Enrolled Patients

Location: Convention Center E264

Presenter: David Badesch, MD

Abstract #: 5982

Tuesday, October 23, 2007, 2:30 p.m. - 4:00 p.m.

Session: Pulmonary Vascular Disease: Pulmonary HTN, ID # 900

Oral Presentation: Bosentan improves hemodynamics in patients receiving

background Sildenafil treatment: results from EARLY, a randomized,

double-blind, placebo controlled study in patients with mildly

symptomatic pulmonary arterial hypertension

Location: Convention Center E266

Presenter: Lewis Rubin, MD

Abstract #: 5356

Session: Pulmonary Vascular Disease : Pulmonary HTN, ID # 900

Oral Presentation: Acute hemodynamic effect of Sildenafil in comparison

with inhaled nitric oxide in patients receiving Bosentan therapy for

pulmonary arterial hypertension (COMPASS-1)

Location: Convention Center E266

Presenter: Nazzareno Galie,
'/>"/>

SOURCE Actelion Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ... Oral Amphotericin B (Oral Amp B) drug candidate ... ImmuneCarta®, the immune monitoring business unit of Caprion, ... Amp B in reactivating latent HIV viral reservoirs ... with antiretroviral therapy. Memory cells, ...
(Date:8/18/2014)... Tampa, FL (Aug. 18, 2014) -- A new ... South Florida (USF) Morsani College of Medicine and ... the life-threatening complications of interventional cardiovascular disease treatment. ... model that the novel molecular therapy could selectively ... healing following a medical procedure using a balloon ...
(Date:8/18/2014)... 2014   Sterne, Kessler, Goldstein & Fox P.L.L.C. ... Washington, DC , announced today that it has ... (IPR) with the U.S. Patent and Trademark Office (USPTO) ... Laboratories, Inc. (Nasdaq: BRLI).  These IPR petitions aim to ... Genetics, Inc. These patents have been asserted against GeneDx ...
(Date:8/18/2014)... YORK , August 18, 2014 ... published by Transparency Market Research "Life Science Reagents ... Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and ... and Academic Institutions, Clinical Laboratories, and Forensic Laboratories)- ... Forecast, 2013 - 2019", the global life science ...
Breaking Biology Technology:iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5
... Quarterly presents a 360-degree look at the "state of ... drugs. This CQ Forum will include a panel discussion ... regarding the complex structures of biologics products vs. traditional ... these products save money for consumers? What is the ...
... June 15 Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: ... new class of small molecule compounds based on endogenous adrenal ... James M. Frincke Ph.D. as President and CEO of Hollis-Eden ... company,s board of directors. , , Dr. Frincke joined ...
... June 15 Nanopoint Inc., an award-winning developer ... announced that effective immediately its cellTRAY Imaging System ... European marketplace. Nanopoint,s cellTRAY Imaging and Fluidics Systems ... including drug discovery, assisted reproductive technology (ART), stem ...
Cached Biology Technology:Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 2Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO 3Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems 2
(Date:8/19/2014)... lemur. It,s not an African Bush Baby or even a ... downright "cool" primate from Southeast Asia. , "It,s really not ... Brown, curator-in-charge at the University of Kansas, Biodiversity Institute. "A ... body; a long tail with a furry tuft at the ... a bit like the disks on the digits of tree ...
(Date:8/19/2014)... retail seafood counters in 10 different states show ... to unexpectedly high levels of mercury, a harmful ... fish of the same species, but from a ... according to new research by University of Hawai,i ... is essential to allow consumers to choose sustainable ...
(Date:8/19/2014)... identified a biomarker strongly associated with basal-like breast ... to many types of chemotherapy. The biomarker, a ... new therapeutics designed to treat this often deadly ... from The Cancer Genome Atlas, molecular biologists Curt ... computational and bioinformatics techniques to detect patterns of ...
Breaking Biology News(10 mins):Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3
... and vegetables instead of cookies and soda pop. Consider ... applaud a lunchtime workout rather than criticizing the cut ... encourages walking the stairs instead of riding the elevator. ... by Community Health Councils, Inc. (CHC) in Los Angeles ...
... Cold Spring Harbor Laboratory on Long Island have identified which ... the chief target of the widely prescribed antidepressant Prozac. This ... for depression, with fewer side effects, to be developed. , ... the factors that control how, when, and where new neurons ...
... tumor and settles in a new location, where it ... assays for this process, which is known as metastasis, ... across the surface of a matrix, traveling in a ... approach misses some crucial phenomena. , Working in the ...
Cached Biology News:UCLA study of community health project shows how group dynamics affect fitness, eating habits 2UCLA study of community health project shows how group dynamics affect fitness, eating habits 3Prozac's target revealed 23-D model reveals secrets of metastasis 2
... The Varian 500-MS LC Ion Trap ... high-throughput LC/MS analysis where sensitivity, reliability ... 500-MS provides a robust platform for ... mass resolution, and mass stability reflect ...
... This modular benchtop fume ... fumes, allowing safe indoor release ... remove most organic contaminants. Configurations ... horizontal flow; options include final ...
... for biological safety labs (BSL) and ... Class 10/ISO 3) and easy sterilization. ... surfaces that are easy to wipe ... simplify cleaning. Unique double-wall panel design ...
... The new Hummingbird has the ability to quickly ... plate makes it a perfect candidate for inclusion ... simple OCX interface supplied with all the Cartesian ... store. Hummingbirds ability to copy plates in ...
Biology Products: